Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems

Olim, Filipe; Neves, Ana Rute; Wang, Zhao; Sun, Jingjing; Tomás, Helena; Sheng, Ruilong

http://hdl.handle.net/10400.13/3820

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Prodrug Systems (I) Lipid-Based Doxorubicin Prodrugs and Their Nanodelivery Systems.pdf		517.97 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Using natural lipids to covalently connect with antitumor agents to construct lipid-based molecular prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry, nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin (molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally, possible future research outlooks in this field were also discussed.

Keywords

Lipid Doxorubicin Prodrugs Stimuli-responsive Drug co-delivery Nanosystems . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira

URI

http://hdl.handle.net/10400.13/3820

Citation

Olim, F., Neves, A. R., Wang, Z., Sun, J., Tomás, H., & Sheng, R. (2020). Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems. Medicine Research, 4(1-2), 200013. DOI: 10.21127/yaoyimr20200013